The association between RAB33A (RAB33A, Member RAS Oncogene Family) and Combined Oxidative Phosphorylation Deficiency is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants360
Symptoms0
Compounds0
Trials0
Publications6
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.